The specific roles of CSPG4 in cancer immune responses remain largely unexplored, necessitating further research to determine whether CSPG4 interactions can enhance CSPG4-targeted immunotherapy or mitigate negative immunomodulatory effects. The gene discussed is CSPG4; the disease is cancer.